Journal of Medical Economics, Volume 15, Issue 4 (2012)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 15, Issue 4 (2012)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Volume 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Review

Article
Improving prevention and treatment of venous thromboembolism: clinical trial results
Charles Mahan & Alex C. Spyropoulos
Pages: 611-622
Published online: 28 Feb 2012
AbstractforImproving prevention and treatment of venous thromboembolism: clinical trial results | Full Text | References | PDF (223.8 KB)
  • 821 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
The threshold rate of oral atypical anti-psychotic adherence at which paliperidone palmitate is cost saving
Natalie C. Edwards, Erik Muser, Dilesh Doshi & John Fastenau
Pages: 623-634
Published online: 29 Feb 2012
AbstractforThe threshold rate of oral atypical anti-psychotic adherence at which paliperidone palmitate is cost saving | Full Text | References | PDF (306.3 KB)
  • 922 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access
Article
Tumor necrosis factor blocker dose escalation among biologic naïve rheumatoid arthritis patients in commercial managed-care plans in the 2 years following therapy initiation
Machaon M.K. Bonafede, Shravanthi R. Gandra, Kathleen M. Fox & Kathleen L. Wilson
Pages: 635-643
Published online: 01 Mar 2012
AbstractforTumor necrosis factor blocker dose escalation among biologic naïve rheumatoid arthritis patients in commercial managed-care plans in the 2 years following therapy initiation | Full Text | References | PDF (917.2 KB)
  • 790 Views
  • 23 CrossRef citations
  • 0Altmetric
Free Access
Article
In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty
F. Vekeman, J. C. LaMori, F. Laliberté, E. Nutescu, M. S. Duh, B. K. Bookhart, J. Schein, K. Dea, W. H. Olson & P. Lefebvre
Pages: 644-653
Published online: 12 Mar 2012
AbstractforIn-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty | Full Text | References | PDF (180 KB)
  • 735 Views
  • 19 CrossRef citations
  • 0Altmetric
Free Access
Article
Long-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States
Anne-Laure Guillermin, Adam Lloyd, Jennie H. Best, Mary Beth DeYoung, Yevgeniy Samyshkin & Julia Aledort Gaebler
Pages: 654-663
Published online: 12 Mar 2012
AbstractforLong-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States | Full Text | References | PDF (103.8 KB)
  • 1656 Views
  • 19 CrossRef citations
  • 0Altmetric
Free Access
Article
Direct and indirect costs associated with Dupuytren’s contracture
Dendy Macaulay, Jasmina Ivanova, Howard Birnbaum, Rachael Sorg & Paul Skodny
Pages: 664-671
Published online: 21 Mar 2012
AbstractforDirect and indirect costs associated with Dupuytren’s contracture | Full Text | References | PDF (92.5 KB)
  • 597 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access
Article
Healthcare utilization among patients with depression before and after initiating duloxetine in the United Kingdom
Nianwen Shi, Zhun Cao, Emily Durden, Alexander Schacht, Amelito Torres & Michael Happich
Pages: 672-680
Published online: 20 Mar 2012
AbstractforHealthcare utilization among patients with depression before and after initiating duloxetine in the United Kingdom | Full Text | References | PDF (159.6 KB)
  • 420 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
Elicitation of health state utilities in neuroendocrine tumours
P. Swinburn, J. Wang, D. Chandiwana, W. Mansoor & A. Lloyd
Pages: 681-687
Published online: 20 Mar 2012
AbstractforElicitation of health state utilities in neuroendocrine tumours | Full Text | References | PDF (123.3 KB)
  • 886 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access
Article
Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States
Alex Z. Fu & Mehul Jhaveri
Pages: 688-694
Published online: 21 Mar 2012
AbstractforHealthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States | Full Text | References | PDF (142.6 KB)
  • 739 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness of dabigatran etexilate for stroke prevention in non-valvular atrial fibrillation. Applying RE-LY to clinical practice in Denmark
Lars K Langkilde, Mikael Bergholdt Asmussen & Mikkel Overgaard
Pages: 695-703
Published online: 22 Mar 2012
AbstractforCost-effectiveness of dabigatran etexilate for stroke prevention in non-valvular atrial fibrillation. Applying RE-LY to clinical practice in Denmark | Full Text | References | PDF (152.7 KB)
  • 987 Views
  • 37 CrossRef citations
  • 0Altmetric
Free Access
Article
Evaluating the length of stay and value of time in a pediatric emergency department with two models by comparing two different albuterol delivery systems
Lauren Staggs, Meagan Peek, Gary Southard, Ed Gracely, Sidney Baxendale, Keith P. Cross & In K. Kim
Pages: 704-711
Published online: 23 Mar 2012
AbstractforEvaluating the length of stay and value of time in a pediatric emergency department with two models by comparing two different albuterol delivery systems | Full Text | References | PDF (215.1 KB)
  • 1688 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States
Alison Stopeck, Michael Rader, David Henry, Mark Danese, Marc Halperin, Ze Cong, Yi Qian, Roger Dansey & Karen Chung
Pages: 712-723
Published online: 27 Mar 2012
AbstractforCost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States | Full Text | References | PDF (219.1 KB) | Supplemental
  • 2650 Views
  • 44 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine
Robert Ikenberg, Nadine Hertel, R. Andrew Moore, Marko Obradovic, Garth Baxter, Pete Conway & Hiltrud Liedgens
Pages: 724-736
Published online: 28 Mar 2012
AbstractforCost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine | Full Text | References | PDF (437.1 KB)
  • 1390 Views
  • 22 CrossRef citations
  • 0Altmetric
Free Access
Article
Health services research in heart failure patients treated with a remote monitoring device in Germany—a retrospective database analysis in evaluating resource use
Bernd Brüggenjürgen, Carsten W. Israel, Armin A. Klesius, Nadja Ezzat & Stefan N. Willich
Pages: 737-745
Published online: 02 Apr 2012
AbstractforHealth services research in heart failure patients treated with a remote monitoring device in Germany—a retrospective database analysis in evaluating resource use | Full Text | References | PDF (227.3 KB)
  • 442 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Article
Exenatide BID and liraglutide QD treatment patterns among type 2 diabetes patients in Germany
Lesley-Ann Miller, Chakkarin Burudpakdee, Anthony Zagar, Monali Bhosle, Matthew Reaney, Vernon F. Schabert & David Bruhn
Pages: 746-757
Published online: 03 Apr 2012
AbstractforExenatide BID and liraglutide QD treatment patterns among type 2 diabetes patients in Germany | Full Text | References | PDF (259.6 KB)
  • 704 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access
Article
Budget-impact model for colonoscopy cost calculation and comparison between 2 litre PEG+ASC and sodium picosulphate with magnesium citrate or sodium phosphate oral bowel cleansing agents
H.-J. Gruss, A. Cockett & R. J. Leicester
Pages: 758-765
Published online: 03 Apr 2012
AbstractforBudget-impact model for colonoscopy cost calculation and comparison between 2 litre PEG+ASC and sodium picosulphate with magnesium citrate or sodium phosphate oral bowel cleansing agents | Full Text | References | PDF (178.3 KB) | Supplemental
  • 596 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Article
A long-term analysis evaluating the cost-effectiveness of biphasic insulin lispro mix 75/25 and mix 50/50 versus long-acting basal insulin analogs in the United States
Richard F. Pollock, Bradley H. Curtis & William J. Valentine
Pages: 766-775
Published online: 04 Apr 2012
AbstractforA long-term analysis evaluating the cost-effectiveness of biphasic insulin lispro mix 75/25 and mix 50/50 versus long-acting basal insulin analogs in the United States | Full Text | References | PDF (317.9 KB)
  • 843 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Article
Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials
Steve Deitelzweig, Alpesh Amin, Yonghua Jing, Dinara Makenbaeva, Daniel Wiederkehr, Jay Lin & John Graham
Pages: 776-785
Published online: 13 Apr 2012
AbstractforMedical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials | Full Text | References | PDF (472.8 KB)
  • 1910 Views
  • 71 CrossRef citations
  • 0Altmetric
Free Access
Article
Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients
T. Kim Le, Katherine B. Winfree, Hongbo Yang, Maryna Marynchenko, Andrew P. Yu, Christian Frois & Eric Q. Wu
Pages: 786-795
Published online: 20 Apr 2012
AbstractforTreatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients | Full Text | References | PDF (602.6 KB)
  • 913 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Article
Economic and health-related quality-of-life (HRQoL) comparison of lopinavir/ritonavir (LPV/r) and atazanavir plus ritonavir (ATV+RTV) based regimens for antiretroviral therapy (ART)-naïve and -experienced United Kingdom patients in 2011
K. N. Simpson, R. W. Baran, D. Collomb, E. J. Beck, O. Van de Steen & B. Dietz
Pages: 796-806
Published online: 07 Jun 2012
AbstractforEconomic and health-related quality-of-life (HRQoL) comparison of lopinavir/ritonavir (LPV/r) and atazanavir plus ritonavir (ATV+RTV) based regimens for antiretroviral therapy (ART)-naïve and -experienced United Kingdom patients in 2011 | Full Text | References | PDF (242.4 KB)
  • 542 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Explore articles